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Abstract
Background: Cardiac inflammatory myofibroblastic tumor (IMT) is an extremely rare benign entity which
constitutes a small proportion of primary cardiac tumor.
Case presentation: We present a rare case of a 55-year-old symptomatic male patient with a rare cardiac IMT
causing left ventricular outflow tract (LVOT) obstruction. The patient received complete tumor resection
immediately with uneventful postoperative hospital course.
Conclusion: To our best knowledge, cardiac IMT involving aortic valve in older adult causing LVOT obstruction has
never been reported before. Additionally, we make a literature review on IMT, focusing on the various clinical
presentation of this unpredictable tumor.
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Background
Primary cardiac tumors are rare diseases with an autopsy
incidence ranging from 0.0017 to 0.27%. Myxomas and
sarcomas are the most common benign and malignant
cardiac neoplasms, respectively. IMT, previously termed
as plasma cell granuloma or inflammatory pseudotumor,
was first described in lung in 1939 [1]. IMTs most
frequently occur in soft tissues and are composed pre-
dominantly of differentiated myofibroblastic cells accom-
panied by inflammatory mononuclear cells. Cardiac IMT
is extremely rare with unknown etiology, mainly seen in
children and young adults. To our best knowledge, less
than 50 cases about cardiac IMTs have been published
in English over recent decades. Herein, we present a
middle aged male patient with cardiac IMT involving
aortic valve, which caused LVOT obstruction.
Case Presentation
A 55-year-old Chinese male, with no contributory
medical and family history, was admitted to our hospital
because of exertional chest pain for 10 days. Physical
examination revealed a systolic murmur (Grade II) in
the left third intercostal space. Laboratory tests were un-
remarkable. The transthoracic echocardiography showed
a pedunculated hyperechoic mass (2.1 × 1.9 × 1.6 cm) at
LVOT, with a 0.5 cm pedicle adhere to the interventricular
septum (Fig. 1a). The transvalvular blood flow velocity
through aortic valve on Doppler mode was 4 m/s, indicat-
ing severe LVOT obstruction caused by the mass. Further
assessment by computed tomographic angiography of cor-
onary artery showed a spherical high density mass, which
located at the LOVT, without coronary artery disease.
Tumor resection was performed via median sternot-
omy under general anesthesia and the cardiopulmonary
bypass was established with aortic and right atrial
cannulation. An aortotomy revealed a mass, about 3 ×
2.5 cm in size, locating at the LVOT inferior to the aor-
tic valve with a pedicle, about 0.5 cm in diameter, rising
from the interventricular septum (Fig. 1b). In addition,
the aortic valve was found extensively invaded by the
tumor, especially the right coronary cusp and the non-
coronary cusp. Simply tumor resection seemed impossible
owing to the tumor location and widely involvement.
Finally, the patient received complete tumor resection as
well as aortic valve replacement with a 23 cm mechanical
valve (Carbomedics, Sorin Group, Italy) (Fig. 1c). The
pathological examination confirmed the diagnosis of IMT
(Fig. 1d). The patient had an uneventful recovery without
any complications and he was discharged home on the 7th
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postoperative day. The patient has been followed up for
2 years without any sign of recurrence.
Discussion
IMTs occur mainly in the soft tissues and are composed
with predominantly of inflammatory and myofibroblastic
cells. It is Brunn who described the first case of IMT in
the lungs in 1939 [1]. Although it has been described in
various lesions, cardiac lesions are much more uncom-
mon. With our best knowledge, less than 50 cases of
cardiac IMTs have been published in English since the
initial description made by Gonzalez-Crussi in 1975 [2].
Owing to its extremely rarity, the etiology of IMT still
remains unresolved and the immunologic and infectious
postulates are still to be validated.
According to our literature review, it may seem
premature to establish an epidemiologic profile of
cardiac IMT owing to its rarity, but several features are
concluded: no gender predominance, predilection for
children and young adult. More than two thirds of the
cardiac IMT cases have been reported in children and
adolescents. To our best knowledge, less than 10 cases
of cardiac IMT involving older adult patients have been
published before, which makes our case much rarer.
Histologically, IMT consists of a proliferation of spindle-
shaped cells associated with no remarkable atypia or
mitotic activity, corresponding to fibroblasts and myofi-
broblasts arranged in a myxoid stroma made of a diffuse
inflammatory infiltration with a heterogeneous cell
admixture, dominated by histiocytes and plasmocytes.
Immunohistochemical analysis is highly contributive to
the differential diagnosis, objectifying universally positive
for vimentin, universally negative for CD34 and generally
positive for CD68 and smooth muscle actin antibodies [3].
The clinical presentation of IMT depends on multiple
factors including patient age, tumor size, location, rate
of growth and individual tolerance. Patients with cardiac
IMT are usually asymptomatic until hemodynamic
changes and local invasion leading to cardiac insuffi-
ciency. Decreased exercise tolerance may be the most
common symptom in the patients with cardiac IMT.
Arrhythmia may emerge when the conduction system is
involved or ectopic excitation foci occurs. Once the valves
are involved, symptoms related to valvular stenosis or re-
gurgitation like lower extremity edema, dyspnea, syncope,
chest pain may manifest. Moreover, fever of unknown ori-
gin is another possible symptom of IMT which suggested
the nature of immunological-related.
The natural history of IMT is unpredictable. Patients
undergoing surgical resection of the tumor usually have a
favorable prognosis, while patients with an unresectable
tumor may have a poor one because of the unpredictable
progression of the tumor, like sudden death or embolism.
Spontaneous or steroid –induced regression have also
been reported in cardiac IMT [4, 5].
There is consensus about surgical treatment in symp-
tomatic patients with cardiac IMT [6], but it is still con-
troversial whether performing surgery in asymptomatic
Fig. 1 a Transthoracic echocardiography showed a well-defined homogenous hyperechoic mass (2.1 × 1.9 × 1.6 cm) at the LVOT. b An aortotomy
revealed a mass (in black arrow) locating at the LVOT, inferior to the aortic valve. c The non-coronary cusp and right coronary cusp of the aortic
valve was involved by the tumor. The tumor was totally resected and the aortic valve was removed. d Pathological study of the tumor showed
severe proliferation of the myofibroblastic cells, surrounded by suppurative inflammatory tissues and extensive formation of granulomas which
confirmed the diagnosis of inflammatory myofibroblastic tumor (Hematoxylin & eosin, magnification, ×40). (LVOT = Left ventricular outflow tract)
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patients. Recurrence of IMT is more likely to occur in
patients with incomplete tumor resection. No distant
metastasis has been documented.
Conclusion
Cardiac IMT is an extremely rare entity which consti-
tutes only a few percent of primary cardiac tumors. This
case report describes a rare cardiac IMT involving aortic
valve in an older adult patient which has seldomly been
reported before. Its etiology still remains controversy.
Current consensus regarding optimal treatment for IMT
is complete tumor resection which is associated with
favorable long-term outcomes.
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